Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity

Details for Australian Patent Application No. 2011206584 (hide)

Owner UCB Pharma S.A.

Inventors Ellis, Mark; Humphreys, David Paul

Agent Griffith Hack

Pub. Number AU-A-2011206584

PCT Pub. Number WO2011/086136

Priority 1000587.4 14.01.10 GB

Filing date 13 January 2011

Wipo publication date 21 July 2011

International Classifications

C12N 15/70 Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C07K 14/245 Peptides having more than 20 amino acids

Event Publications

26 July 2012 PCT application entered the National Phase

  PCT publication WO2011/086136 Priority application(s): WO2011/086136

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011206586-Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene

2011206574-Compounds for the treatment of autism